Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹1,022.00
Market cap
₹2,145 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
32.3×Sector 47.3×
Promoter holding
63.31%+1.41% QoQ
FII holding
2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:06 IST BSE
Debt & Borrowing

Windlas Biotech Debt & Borrowing

Windlas Biotech Limited confirmed it does not fall under the 'Large Corporate' category for the financial year 2026-27 as per SEBI criteria. The company reported zero outstanding borrowings as of March 31, 2026, and maintains an ICRA A+ credit rating.